A patient with glucose-6-phosphate dehydrogenase (G6PD) deficiency accidentally ingested fava beans and presents to the emergency department with stable vital signs and appears well. What is the appropriate management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Asymptomatic G6PD Patient After Fava Bean Ingestion

For a G6PD-deficient patient who accidentally consumed fava beans but presents to the ER asymptomatic with stable vital signs, close clinical observation with serial laboratory monitoring is the appropriate management—no immediate treatment is required unless hemolysis or methemoglobinemia develops. 1

Initial Assessment and Monitoring

Baseline Laboratory Evaluation

  • Obtain immediate workup including: 2
    • Complete blood count (CBC) with peripheral smear looking for bite cells, schistocytes, and evidence of hemolysis
    • Reticulocyte count
    • Lactate dehydrogenase (LDH), haptoglobin, indirect bilirubin
    • Direct and indirect Coombs test
    • Methemoglobin level via co-oximetry (blood gas analysis)
    • Free hemoglobin and urinalysis for hemoglobinuria

Clinical Observation Protocol

  • Monitor for signs and symptoms of acute hemolysis: 3, 4

    • Jaundice (typically appears 24-48 hours post-ingestion)
    • Dark urine (hemoglobinuria)
    • Back or abdominal pain
    • Fatigue and pallor
    • Tachycardia or dyspnea
  • Monitor for methemoglobinemia: 1, 3

    • Cyanosis despite adequate oxygen saturation on pulse oximetry
    • Discrepancy between pulse oximetry reading and arterial blood gas oxygen saturation
    • Chocolate-brown colored blood

Management Based on Clinical Status

Asymptomatic Patients (Current Scenario)

Since the patient appears well with stable vital signs, observation without immediate treatment is appropriate. 1

  • Provide supplemental oxygen if needed based on clinical assessment 1
  • Serial hemoglobin monitoring (initially every 4-6 hours, then daily until stable) 2
  • Observe for at least 24-48 hours as hemolysis may be delayed 3, 5
  • Ensure adequate hydration to prevent acute kidney injury from hemoglobinuria 4

If Hemolysis Develops

  • Supportive care with hydration and monitoring 3, 6
  • Transfuse packed red blood cells only if: 2
    • Hemoglobin drops to <7-8 g/dL in stable patients
    • Patient develops symptomatic anemia
    • Transfuse minimum units necessary to relieve symptoms

If Methemoglobinemia Develops

CRITICAL CAVEAT: Methylene blue is absolutely contraindicated in G6PD deficiency patients. 1, 7, 3

  • Methylene blue can worsen hemolysis and is ineffective in G6PD deficiency because these patients lack sufficient NADPH (produced by G6PD) to convert methylene blue to its active reducing form, leukomethylene blue 1

Alternative treatments for methemoglobinemia in G6PD patients: 1

  • Ascorbic acid (Vitamin C): First-line treatment for methemoglobinemia in G6PD deficiency

    • Adult dosing: 1-2 g IV every 4-12 hours (various regimens reported: 0.5-10 g)
    • Pediatric dosing: 0.5-1 g every 4-12 hours
    • Effect is slow (may take 24+ hours to reduce methemoglobin levels)
  • Exchange transfusion: For severe, life-threatening methemoglobinemia unresponsive to ascorbic acid 1, 7

  • Hyperbaric oxygen therapy: May be considered as adjunctive therapy 1, 7

  • Supplemental oxygen: Always provide to maximize oxygen delivery 1

Discharge Planning and Education

Patient Counseling (Essential)

  • Educate on strict avoidance of: 1, 8

    • Fava beans (all forms)
    • Oxidative medications: dapsone, primaquine, rasburicase, pegloticase, methylene blue, sulfonamides, nitrofurantoin, phenazopyridine
    • Naphthalene (mothballs)
    • Henna products
  • Provide written list of safe and unsafe medications 8

  • Medical alert bracelet recommended 1

  • Counsel to seek immediate care if: 3, 8

    • Dark urine develops
    • Jaundice appears
    • Severe fatigue or pallor
    • Any signs of infection (common trigger for hemolysis)

Follow-up

  • Recheck hemoglobin and reticulocyte count in 3-7 days 2
  • Confirm G6PD deficiency diagnosis if not previously documented 8
  • Screen first-degree relatives, especially male siblings and maternal relatives 1

Key Clinical Pitfalls to Avoid

  1. Never administer methylene blue to G6PD-deficient patients—it will worsen hemolysis and is ineffective 1, 3

  2. Do not discharge too early—hemolysis can be delayed 24-48 hours after fava bean ingestion 3, 5

  3. Do not miss methemoglobinemia—check methemoglobin levels in all G6PD patients with fava bean exposure, as it can co-occur with hemolysis 3, 4

  4. Monitor for acute kidney injury—hemoglobinuria can cause renal tubular damage; maintain adequate hydration 4

  5. Remember that severity varies—even the same patient can have different severity of hemolytic episodes with repeated exposures 5, 8

Related Questions

What are the treatment recommendations for patients with Glucose-6-phosphate dehydrogenase (G6PD) deficiency?
What are the recommended management and preventive measures for a patient with glucose‑6‑phosphate dehydrogenase (G6PD) deficiency?
Can Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency present in a 9-month-old child?
What is the significance of Fava (Fava beans) in medical conditions, particularly in relation to G6PD (Glucose-6-phosphate dehydrogenase) deficiency?
What is Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency?
What is the diagnostic approach for seronegative rheumatoid arthritis?
How many people worldwide have magnesium deficiency?
For diagnosing a suspected fungal skin infection, should I use a patch test, skin biopsy, a 10% potassium hydroxide (KOH) smear, or a Wood's lamp examination?
In a patient with stimulant and opioid use disorder currently on naltrexone, who last used fentanyl a week ago and now has withdrawal symptoms (anxiety, restlessness, feeling of wanting to jump out of his skin), can I initiate buprenorphine‑naloxone (Suboxone) one day after discontinuing naltrexone, and what initial dose should be given?
What is the process for using intravenous ketamine to treat major depressive disorder with acute suicidal ideation?
What hemoglobin thresholds indicate the need for red blood cell transfusion in stable adults, adults with cardiovascular disease or symptomatic anemia, and in pediatric patients including infants, neonates, and preterm infants?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.